Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
140
about 28 days
40–80
1 site in CA
About this study
This trial is testing if a supplement called Sabroxy® can improve insulin resistance and thinking skills in adults with mild cognitive impairment and insulin resistance. Participants will take either Sabroxy® or a placebo for 8 weeks, and researchers will measure changes in insulin resistance, thinking skills, and other markers of health.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Sabroxy®
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Secondary: Change in Inflammatory Biomarker (High-Sensitivity C-Reactive Protein, hs-CRP), Change in Montreal Cognitive Assessment (MoCA) Total Score
Neurology